Patient-reported outcomes in the phase 3 BFORE trial of bosutinib versus imatinib for newly diagnosed chronic phase chronic myeloid leukemia

1. Cortes, J.E.
2. Gambacorti-Passerini, C.
3. Deininger, M.W.
4. Mauro, M.J.
5. Chuah, C.
6. Kim, D.-W.
7. Milojkovic, D.
8. le Coutre, P.
9. Garcia-Gutierrez, V.
10. Crescenzo, R.
11. Mamolo, C.
12. Reisman, A.
13. Hochhaus, A.
14. Brümmendorf, T.H.